Relpax and Cefuroxime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Cefuroxime (cefuroxime sodium). Common drug interactions include cerebrovascular accident among females.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Cefuroxime. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.



On Aug, 05, 2026

26 people who take Relpax and Cefuroxime together, and have interactions are studied.

Relpax and Cefuroxime drug interactions.

What are the common drug interactions of Relpax and Cefuroxime, by gender? *:

female:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Angiopathy (generic term for a disease of the blood vessels)
  3. Monoparesis (one limb is very weak, but not completely paralyzed)
  4. Monoplegia (a paralysis of a single limb)
  5. Pain in extremity
  6. Speech disorder
  7. Fall
  8. Cardiac failure
  9. Cerebral haematoma (collection of blood in brain)
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

n/a

What are the common drug interactions of Relpax and Cefuroxime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  2. Hepatosplenomegaly (enlargement of both the liver and the spleen)

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Pain
  3. Injury
  4. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Blood potassium decreased
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Feeling hot
  5. Joint swelling
  6. Lyme disease (a bacterial infection that is spread to humans by infected ticks)
  7. Nausea (feeling of having an urge to vomit)
  8. Pain
  9. Peripheral swelling
  10. Rash erythematous (redness of the skin)

50-59:

  1. Activities of daily living impaired
  2. Depression
  3. Facial paresis (weakness in facial muscle movement)
  4. Gait disturbance
  5. Monoparesis (one limb is very weak, but not completely paralyzed)
  6. Monoplegia (a paralysis of a single limb)
  7. Speech disorder
  8. Dizziness
  9. Fall
  10. Cerebral haematoma (collection of blood in brain)

60+:

  1. Cardiac failure
  2. Large intestine perforation (hole in large intestine)
  3. Leukopenia (less number of white blood cells in blood)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  6. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  7. Subileus
  8. Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

  1. Depression: 11 people, 42.31%
  2. Pain: 10 people, 38.46%
  3. Bacterial Infection: 8 people, 30.77%
  4. Cough: 7 people, 26.92%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 19.23%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
  7. Constipation: 3 people, 11.54%
  8. Headache (pain in head): 3 people, 11.54%
  9. Urinary Tract Infection: 2 people, 7.69%
  10. Dysmenorrhea (painful menstruation): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Cefuroxime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Relpax and Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relpax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefuroxime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide and cefuroxime sodium (the active ingredients of Relpax and Cefuroxime, respectively), and Relpax and Cefuroxime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: